News
GE Digital 2020 User Conference: From Resilience to Innovation
GE Digital today begins a three-day virtual User Conference featuring stories of companies in multiple industries on their path to digital transformation: enabling more renewable energy on the
GE Healthcare’s Clariscan™ (gadoterate meglumine) Becomes Only FDA-Approved MRI Contrast Agent Available in Polymer Bottle
GE Healthcare’s innovative shatterproof polymer +PLUSPAK Pharmacy Bulk Package has been approved by the US FDA for use with its macrocyclic gadolinium-based MRI contrast agent, Clariscan
General Electric und der neu entflammte Überlebenskampf
Siemens: Ist Konzernchef Kaeser verrückt geworden?
Das ist kein Scherz: Siemens-Vorstandschef Joe Kaeser bot der Sprecherin des deutschen Ablegers von Friday for Future, Luisa Neubauer, einen Platz im Aufsichtsrat der Energie-Sparte des Siemens-Konz
GE Healthcare Announces U.S. FDA Approval of Macrocyclic MRI Contrast Agent Clariscan™ (gadoterate meglumine) Injection for Intravenous Use
The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE Healthcare portfolio for U.S. patients and